BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31146120)

  • 1. Excessive expressions of T cell activation markers in pediatric immune thrombocytopenia.
    Chen Y; Zhou Y; Chen P; Zhang P; Jia M; Tang Y
    Thromb Res; 2019 Aug; 180():1-9. PubMed ID: 31146120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q; Gong FQ; Shang SQ; Hu J
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
    Gessl A; Waldhäusl W
    Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
    Rea IM; McNerlan SE; Alexander HD
    Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
    Zhang YY; Huang XM; Kang ML; Gong FQ; Qian BQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):329-32. PubMed ID: 16780706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
    Gessl A; Waldhäusl W
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In neonates with vitamin D deficiency, low lymphocyte activation markers are risk factors for infection.
    Youssef MAM; Zahran AM; Hussien AM; Elsayh KI; Askar EA; Farghaly HS
    Paediatr Int Child Health; 2019 May; 39(2):111-118. PubMed ID: 30375272
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis.
    Iannone F; Corrigall VM; Kingsley GH; Panayi GS
    Eur J Immunol; 1994 Nov; 24(11):2706-13. PubMed ID: 7957563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does immune activation continue during an attack-free period in familial Mediterranean fever?
    Musabak U; Sengul A; Oktenli C; Pay S; Yesilova Z; Kenar L; Sanisoglu SY; Inal A; Tuzun A; Erdil A; Bagci S
    Clin Exp Immunol; 2004 Dec; 138(3):526-33. PubMed ID: 15544632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
    Fahim NM; Monir E
    Egypt J Immunol; 2006; 13(1):173-87. PubMed ID: 17974160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping.
    Plaeger-Marshall S; Isacescu V; O'Rourke S; Bertolli J; Bryson YJ; Stiehm ER
    Clin Immunol Immunopathol; 1994 Apr; 71(1):19-26. PubMed ID: 7511081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ CD25+High Foxp3+ regulatory T cells, B lymphocytes, and T lymphocytes in patients with acute ITP in Assiut Children Hospital.
    Zahran AM; Elsayh KI
    Clin Appl Thromb Hemost; 2014 Jan; 20(1):61-7. PubMed ID: 22875869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory molecules in patients with gestational diabetes mellitus.
    Pendeloski KP; Mattar R; Torloni MR; Gomes CP; Alexandre SM; Daher S
    Endocrine; 2015 Sep; 50(1):99-109. PubMed ID: 25754913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients.
    Li F; Ji L; Wang W; Hua F; Zhan Y; Zou S; Yuan L; Ke Y; Min Z; Song D; Sun L; Chen H; Cheng Y
    Immunol Res; 2015 Mar; 61(3):269-80. PubMed ID: 25550089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
    Yacyshyn MB; Poppema S; Berg A; MacLean GD; Reddish MA; Meikle A; Longenecker BM
    Int J Cancer; 1995 May; 61(4):470-4. PubMed ID: 7538976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.